Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.

Featured Stories

Meet The Lead Ozempic Lawyers No Photo Available

The recently deceased U.S. District Judge Gene E.K. Pratter this past spring appointed plaintiff leadership in litigation over Ozempic... (more story)

Dead Or Not Quite: Hospitals Weigh Shared Definition Of DOA No Photo Available

What does it mean to be dead on arrival? Standardizing the definition is vital to the nation's hospital emergency departments, which a... (more story)

Hospital Cites Rare Doctrine In Colo. Trans Care Clash No Photo Available

A Colorado hospital accused of illegally refusing to provide gender-affirming surgery is turning to an unusual defense employed more o... (more story)